相关实验视频

Updated: Jul 17, 2026

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

纳米免疫结合剂在免疫检查点阻塞中:精确免疫疗法和实时成像的双重方法

Dilpreet Singh¹, Neena Bedi²

¹School of Pharmaceutical Sciences, CT University, Sidhwan Khurd, Punjab, India.

Asia-Pacific journal of clinical oncology

|October 17, 2025

概括

纳米免疫结合剂通过精确向瘤并使实时监测成为可能,改善了癌症免疫治疗. 这些先进的平台提高了免疫检查点阻塞 (ICB) 治疗的有效性和安全性.

科学领域:

纳米医学是一种纳米医学.
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

免疫检查点阻塞 (ICB) 疗法提供了革命性的癌症治疗方法,但在瘤向,副作用和反应监测方面面临挑战.
纳米免疫结合剂,结合免疫检查点抑制剂 (ICI) 与纳米平台上的成像剂,解决了这些局限性.

研究的目的:

审查纳米免疫结合物用于增强癌症免疫治疗的开发和应用.
探索它们在精确药物输送,提高疗效和非侵入性监测方面的潜力.

主要方法:

集成ICI (PD-1/PD-L1,CTLA-4) 与各种纳米载体 (脂质体,纳米颗粒,树突体,外体体).
纳入分子成像方式 (PET,MRI,NIRF,光声成像).
分析临床前和早期临床数据的疗效,生物分布和安全性.

主要成果:

在临床前模型中,纳米免疫结合物显示增强T细胞激活,减少瘤负担,改善生物分布.
综合成像允许实时监测药物输送和免疫参与.
早期的临床研究显示了翻译潜力.

结论:

纳米免疫结合剂代表了精确癌症免疫治疗的有希望的下一代战略.
需要进一步的研究来克服免疫性,调节和临床翻译的可扩展性方面的挑战.

关键词:

免疫检查点封锁封锁分子成像分子成像技术纳米免疫结合剂纳米免疫结合剂精确免疫疗法精确免疫疗法它们是天体纳米粒子.瘤微环境是一个微环境.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.